These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17950925)

  • 21. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Choi Y; Min WS; Kim TG; Cho BS; Kim SY; Eom KS; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Kim CC
    Transplantation; 2007 Nov; 84(9):1082-91. PubMed ID: 17998861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haploidentical cellular therapy in elderly patients with acute myeloid leukemia: description of its use in high risk patients.
    Cignetti A; Ruella M; Elia A; Tassi V; Redoglia V; Gottardi D; Tarella C
    Am J Hematol; 2013 Aug; 88(8):720-1. PubMed ID: 23686413
    [No Abstract]   [Full Text] [Related]  

  • 24. Rash as the first manifestation of acute graft-versus-host disease after orthotopic liver transplantation.
    Wu Z; Shi W
    Eur J Dermatol; 2011; 21(6):997-8. PubMed ID: 21856564
    [No Abstract]   [Full Text] [Related]  

  • 25. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
    J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rippled skin, fasciitis, and joint contractures.
    Patel AR; Avila D; Malech HL; Pavletic SZ; Yao L; Cowen EW
    J Am Acad Dermatol; 2008 Dec; 59(6):1070-4. PubMed ID: 19022104
    [No Abstract]   [Full Text] [Related]  

  • 27. Second allogeneic stem cell transplantation in myeloid malignancies.
    Hartwig M; Ocheni S; Asenova S; Wiedemann B; Zabelina T; Ayuk F; Kabisch H; Erttmann R; Kröger N; Zander AR; Bacher U
    Acta Haematol; 2009; 122(4):185-92. PubMed ID: 19887774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship among human herpesvirus 6 reactivation, serum interleukin 10 levels, and rash/graft-versus-host disease after allogeneic stem cell transplantation.
    Kitamura K; Asada H; Iida H; Fukumoto T; Kobayashi N; Niizeki H; Morii T; Kimura H; Miyagawa S
    J Am Acad Dermatol; 2008 May; 58(5):802-9. PubMed ID: 18367292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethmoidal sinusitis caused by Exserohilum rostratum in a patient with malignant lymphoma after non-myeloablative allogeneic peripheral blood stem cell transplantation.
    Togitani K; Kobayashi M; Sakai M; Uemura Y; Taguchi H; Morita T; Sugihara S; Sano A; Nishimura K
    Transpl Infect Dis; 2007 Jun; 9(2):137-41. PubMed ID: 17462000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonhemolytic passenger lymphocyte syndrome with anti-Jk after allogeneic peripheral blood progenitor cell transplantation.
    Leo A; Lenz V; Winteroll S
    Transfusion; 2004 Aug; 44(8):1259-60. PubMed ID: 15265136
    [No Abstract]   [Full Text] [Related]  

  • 31. B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation.
    Iori AP; Torelli GF; De Propris MS; Milano F; Pupella S; Gozzer M; Mancini F; Milani ML; Intoppa S; Cerretti R; Lucarelli B; Valle V; Malandruccolo L; Iannella E; Arleo E; Guarini A; Foà R
    Transplantation; 2008 Feb; 85(3):386-90. PubMed ID: 18322430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid-responsive cauda equina syndrome associated with GVHD after allogeneic hematopoietic stem cell transplantation.
    Terrettaz M; Verholen F; Passweg J; Knipp S; Burkhard PR; Chalandon Y
    Bone Marrow Transplant; 2008 Feb; 41(3):315-6. PubMed ID: 17994117
    [No Abstract]   [Full Text] [Related]  

  • 34. Alloimmune retinopathy associated with antibodies to transducin-alpha as a complication of chronic graft-versus-host disease.
    Wood W; Garg S; Adamus G; Gabriel D; Shea T; Serody J
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):135-8. PubMed ID: 20053338
    [No Abstract]   [Full Text] [Related]  

  • 35. Diffuse pneumatosis due to central venous catheterization in a patient with acute graft-versus-host disease.
    Mikesch JH; Burchert A; Kress O; Ritter M; Görg C; Neubauer A
    Ann Hematol; 2007 Oct; 86(10):767-9. PubMed ID: 17572894
    [No Abstract]   [Full Text] [Related]  

  • 36. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical and FISH analyses identify synovitis associated with chronic GVHD after allogeneic hematopoietic SCT.
    Nozzoli C; Guidi S; Paglierani M; Wnekowicz E; Saccardi R; Bosi A; Santucci M; Massi D
    Bone Marrow Transplant; 2008 Aug; 42(4):289-91. PubMed ID: 18516077
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide.
    Goldsmith SR; Slade M; DiPersio JF; Westervelt P; Lawrence SJ; Uy GL; Abboud CN; Vij R; Schroeder MA; Fehniger TA; Dubberke ER; Trinkaus K; Romee R
    Haematologica; 2016 Nov; 101(11):e465-e468. PubMed ID: 27443287
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor.
    Murashige N; Kami M; Mori S; Katayama Y; Kobayashi K; Onishi Y; Hori A; Kishi Y; Hamaki T; Tajima K; Kanda Y; Tanosaki R; Takaue Y
    Am J Hematol; 2008 Aug; 83(8):630-4. PubMed ID: 18454459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients.
    Pérez A; González-Vicent M; Ramirez M; Sevilla J; Madero L; Díaz MA
    Br J Haematol; 2008 Feb; 140(3):340-3. PubMed ID: 18053071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.